News und Analysen
1 No-Brainer Dividend Stock Yielding More Than 5% to Buy and Hold Forever
When looking to invest in dividend stocks, chasing high yields isn't always an advisable strategy. Companies with juicy yields are only worth investing in provided they can support their payouts. We
Where Will Viking Therapeutics Be in 5 Years?
If you're looking at up-and-coming healthcare stocks with significant potential in the anti-obesity market, one company you've likely come across is Viking Therapeutics (NASDAQ: VKTX). Although the
3 High-Flying Stocks That Could Soar Even More
What's better than a stock that has delivered huge gains? That's easy: A stock that has delivered huge gains and still has a lot of room to run.
We asked three Motley Fool contributors to look among
3 High-Flying Stocks That Could Soar Even More
What's better than a stock that has delivered huge gains? That's easy: A stock that has delivered huge gains and still has a lot of room to run.
We asked three Motley Fool contributors to look among
3 High-Flying Stocks That Could Soar Even More
What's better than a stock that has delivered huge gains? That's easy: A stock that has delivered huge gains and still has a lot of room to run.
We asked three Motley Fool contributors to look among
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
Relax, do what you enjoy, and rake in money. That probably sounds like a great life for most people. Making it a reality isn't easy, but it's possible.
The key is to generate passive income. You'll
Is This Hot IPO the Next Carnival?
The inviting market waters greeted a new cruise line operator earlier this month. Viking (NYSE: VIK) completed its initial public offering (IPO) on May 1, pricing a little more than 64 million
2 Stocks That Could 10x by 2035
Things aren't so bad for investors right now. We are in a bull market even though the economy is still having some problems. However, this bull run won't last forever. There will be a slowdown
Medtronic (MDT) Q4 2024 Earnings Call Transcript
Image source: The Motley Fool.
Medtronic (NYSE: MDT)Q4 2024 Earnings CallMay 23, 2024, 8:00 a.m. ET
Ryan Weispfenning
Source Fool.com
Why Medtronic Stock Slumped Today
Medtronic (NYSE: MDT) stock slipped 2.8% through 10:15 a.m. ET this morning despite beating earnings forecasts in its fiscal Q4 2024 earnings report.
Heading into earnings, analysts had the medical
3 Stocks That Have Turned $25,000 Into More Than $1 Million in 15 Years
The Great Recession ended nearly 15 years ago. Buying stocks toward the end of an economic slowdown can lead to some oversize returns down the road since that usually means you're buying them at
3 Stocks That Have Turned $25,000 Into More Than $1 Million in 15 Years
The Great Recession ended nearly 15 years ago. Buying stocks toward the end of an economic slowdown can lead to some oversize returns down the road since that usually means you're buying them at
3 Stocks That Have Turned $25,000 Into More Than $1 Million in 15 Years
The Great Recession ended nearly 15 years ago. Buying stocks toward the end of an economic slowdown can lead to some oversize returns down the road since that usually means you're buying them at
EQS-News: Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group – Strategic reset of Moulded Glass business
EQS-Adhoc: Gerresheimer to acquire Blitz LuxCo Sarl, the holding company of the Bormioli Pharma Group / Moulded Glass business to be strategically reviewed
Better Buy: Inovio Pharmaceuticals vs. Novavax
The COVID-19 vaccine was worth tens of billions of dollars, but most of it went into the hands of Moderna and Pfizer. Smaller biotechs that tried to dominate this market were much less successful
A Must-Own Stock for Any Portfolio
When it comes to investing, I often look for companies that generate strong amounts of free cash flow (FCF), and companies that can grow their FCF. One company that has proven that over the years is
Is It Too Late to Buy Viking Therapeutics Stock?
Up 260% so far this year, shares of Viking Therapeutics (NASDAQ: VKTX) are a hot commodity thanks to its increasingly promising therapies in development to treat obesity. But as wise investors know
2 Billion More Reasons to Buy AbbVie Stock
There are plenty of reasons to buy a leading biopharma business like AbbVie (NYSE: ABBV), and investors just got at least a few more. Thanks to a large acquisition that came out of left field, it
3 Things You Need to Know If You Buy Novavax Today
Novavax (NASDAQ: NVAX) stock has both soared and plummeted at times in recent years. Investors initially bet on the biotech company to be a winner in the coronavirus vaccine race, sending the stock
EQS-News: Evotec reports Q1 2024 results and provides corporate update
Billionaires Are Buying Beaten-Down Pfizer Stock Hand Over Fist. Should You Follow Their Lead?
The past couple of years haven't been easy ones to be a Pfizer (NYSE: PFE) shareholder. The windfall profits its COVID-19 products produced in the early days of the pandemic evaporated much faster
Billionaires Are Buying Beaten-Down Pfizer Stock Hand Over Fist. Should You Follow Their Lead?
The past couple of years haven't been easy ones to be a Pfizer (NYSE: PFE) shareholder. The windfall profits its COVID-19 products produced in the early days of the pandemic evaporated much faster
1 Wall Street Analyst Thinks AbbVie Stock Is Going to $200. Is It a Buy at Around $165?
Wall Street is feeling pretty good about AbbVie's (NYSE: ABBV) performance in 2024 so far.
Louise Chen from Cantor Fitzgerald recently initiated coverage on the stock with an overweight rating. Chen
3 Reliable Dividend Stocks With Yields Above 5% You Can Buy With Less Than $100 Right Now
Investors looking to pad their passive income streams with high-yield dividend stocks have three excellent choices. If you have an extra $100 to invest, you could set yourself up with dividends from